PL344981A1 - Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty - Google Patents

Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Info

Publication number
PL344981A1
PL344981A1 PL99344981A PL34498199A PL344981A1 PL 344981 A1 PL344981 A1 PL 344981A1 PL 99344981 A PL99344981 A PL 99344981A PL 34498199 A PL34498199 A PL 34498199A PL 344981 A1 PL344981 A1 PL 344981A1
Authority
PL
Poland
Prior art keywords
ghs
serm
selective
growth hormone
estrogen receptor
Prior art date
Application number
PL99344981A
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL344981A1 publication Critical patent/PL344981A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL99344981A 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty PL344981A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
PL344981A1 true PL344981A1 (en) 2001-11-19

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99344981A PL344981A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Country Status (30)

Country Link
EP (1) EP1087764A1 (en)
JP (1) JP2002518326A (en)
KR (1) KR20010052852A (en)
CN (1) CN1301160A (en)
AP (1) AP9901582A0 (en)
AR (1) AR018869A1 (en)
AU (1) AU4054799A (en)
BG (1) BG105041A (en)
BR (1) BR9911324A (en)
CA (1) CA2335134A1 (en)
CO (1) CO5070587A1 (en)
EA (1) EA200001186A1 (en)
GT (1) GT199900087A (en)
HN (1) HN1999000097A (en)
HR (1) HRP20000859A2 (en)
HU (1) HUP0102505A3 (en)
ID (1) ID27599A (en)
IL (1) IL138630A0 (en)
IS (1) IS5691A (en)
MA (1) MA26652A1 (en)
NO (1) NO20006312L (en)
OA (1) OA11505A (en)
PA (1) PA8475901A1 (en)
PE (1) PE20000646A1 (en)
PL (1) PL344981A1 (en)
SK (1) SK18912000A3 (en)
TN (1) TNSN99124A1 (en)
TR (1) TR200003544T2 (en)
WO (1) WO1999065486A1 (en)
ZA (1) ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
EP1156120B1 (en) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
JP2004507502A (en) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク Sustained release formulation for growth hormone secretagogue
US7476653B2 (en) * 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
BRPI0807046A2 (en) 2007-02-09 2015-05-26 Tranzyme Pharma Inc Compound, pharmaceutical composition, methods of treating a disorder, cardiovascular disease and a patient suffering from reduced or dysfunctional gastrointestinal motility and, kit.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
ID27599A (en) 2001-04-12
ZA993975B (en) 2000-12-15
NO20006312D0 (en) 2000-12-12
HUP0102505A2 (en) 2001-11-28
IL138630A0 (en) 2001-10-31
CO5070587A1 (en) 2001-08-28
AR018869A1 (en) 2001-12-12
HUP0102505A3 (en) 2002-12-28
TR200003544T2 (en) 2001-04-20
HN1999000097A (en) 1999-11-03
JP2002518326A (en) 2002-06-25
IS5691A (en) 2000-10-27
MA26652A1 (en) 2004-12-20
OA11505A (en) 2004-05-07
HRP20000859A2 (en) 2001-04-30
PE20000646A1 (en) 2000-08-05
AP9901582A0 (en) 1999-06-30
NO20006312L (en) 2000-12-12
SK18912000A3 (en) 2001-10-08
EA200001186A1 (en) 2001-06-25
AU4054799A (en) 2000-01-05
GT199900087A (en) 2000-12-07
PA8475901A1 (en) 2000-05-24
EP1087764A1 (en) 2001-04-04
WO1999065486A1 (en) 1999-12-23
BG105041A (en) 2001-08-31
BR9911324A (en) 2001-04-03
CA2335134A1 (en) 1999-12-23
CN1301160A (en) 2001-06-27
KR20010052852A (en) 2001-06-25
TNSN99124A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
IL145937A0 (en) Methods and apparatus for secure distribution of software
GB9601049D0 (en) Methods of and apparatus for forming nozzles
HUP0104993A3 (en) Method and device for controlled delivery of active agents
EP1003450A4 (en) Method and apparatus for inducing hypothermia
HUP0102951A3 (en) Apparatus for treatment of meniere's disease and similar conditions
PL336701A1 (en) Treatment of central nervous system diseases using selective modulators of oestrogen receptors
PL345064A1 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
IL138630A0 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
GB2326358B (en) Improved positioning device for concave of cone crusher
PL345588A1 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
HUP0003340A3 (en) Process and apparatus for preparation of vesicles
PL339365A1 (en) Apparatus for and method of feeding pieces of cake
GB9913560D0 (en) Mixing apparatus and method of mixing
PL336422A1 (en) Method of and apparatus for preparing asphalt mixes
DK0931454T3 (en) Apparatus for comminution and mixing of animal feed components
GB2319519B (en) Adjustment of mosaic spread for HOPG material
IL117770A0 (en) Method and apparatus for growing of extended crystals
GB9717211D0 (en) Improvements relating to means of controlling different apparatus
PL335477A1 (en) Method of and apparatus for controlling operation of snow removing mixture spreader
GB9817579D0 (en) Method of and apparatus for controlling headway
HUP9801165A3 (en) Process and apparatus for fire-prevention of cable-lines and this protekted cable-line
GB9908411D0 (en) Method and apparatus for controlled distribution of supports in combinatorial synthesis
IL132369A0 (en) Method of treatment of scalp and hair and formulations for implementation of this method
PL337444A1 (en) Method of and apparatus for meteringly dispensing predetermined portions of material
TW362757U (en) Improvement for protection apparatus of water heater

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)